The startup that should have raised less
Round size should be tied to the next risk the company must remove, not to what sounds like a real seed round.
A founder I will keep anonymous wanted to raise $4M. The business needed about $1.2M. When I asked what the extra $2.8M was for, the answer was three versions of "optionality" and one honest sentence: "$4M sounds like a real seed round. $1.2M sounds like we couldn't get more."
That instinct is the most expensive one in fundraising, and it is almost never examined. The round size gets chosen the way you choose a number to anchor a negotiation, big enough to sound serious, round enough to fit a headline. Then the milestone gets reverse-engineered to justify it. The order is backwards. The round should be sized to the next risk you have to remove, and the risk should pick the number.
The founder who raises to the risk closes faster, dilutes less, and sets a valuation they can clear. The founder who raises to the headline buys eighteen months of runway and a post-money valuation that becomes the hardest number in the company.
What founders do today
Round size gets decided by three bad inputs, in roughly this order.
The first is ego. A bigger round reads as a bigger win. It announces better on LinkedIn, it impresses the people you went to school with, and for a few weeks it feels like the company is further along than it is. None of that survives contact with the next raise.
The second is the market headline. The founder reads that "seed rounds are now $3-5M" and treats that as a spec rather than a distribution. Averages are pulled up by outliers and by companies with traction you do not have yet. Sizing to the average means sizing to someone else's milestone.
The third is fear of running out. This one is legitimate and still leads people astray, because the answer to "what if I need more" is almost always "raise it later at a higher price once you have removed a risk," not "raise it all now at today's price." More cushion feels safer. More cushion is more dilution and a higher bar, both paid in advance for a safety you may not use.
What is missing from all three is the only input that should matter: what is the single most important thing this business has not yet proven, and what does proving it cost.
The framework: size to the next risk
Every company at every stage has one dominant unknown. The thing that, if you removed it, would make the next round obvious. Not five things. One. Naming it is the whole exercise.
At pre-seed the dominant risk is usually "can this team build the thing and find any pull at all." At seed it is usually "is there a repeatable way to acquire customers who stay." At Series A it is usually "does this become a real business when we pour fuel on the working channel." Your specific risk may differ, but you have one, and you can name it in a sentence that starts with "we have not yet proven that."
Once you name the risk, the round sizes itself in three steps.
First, define the proof. What observable outcome would convince a competent investor that the risk is gone. Not "traction." A number: $50K MRR, ten paying logos in the target segment, a payback period under twelve months, a second acquisition channel that works without you in the room.
Second, cost the path to that proof. What headcount, runway, and spend does it take to get from here to that number, plus the buffer to run the next raise without panic. This is a build estimate, not a wish. It usually comes out smaller than the headline number, which is why founders avoid doing it.
Third, add a margin for being wrong about the timeline, not for adding scope. Twenty to forty percent more runway, not a second milestone bolted on. The margin protects the plan you have. It does not fund a plan you have not made.
The output is a number that maps to one proof point. If you cannot connect every dollar to removing the named risk, you are raising to the headline.
The two failure modes
Over-raising and under-raising fail differently, and most advice only warns about one.
Over-raising sets a valuation you have to grow into before you can raise again. Raise $4M at a $16M post when the business supports a $1.2M round at a $6M post, and you have not bought freedom. You have bought a $16M floor. The next investor prices off your last post, and if you have not roughly tripled the business, you are looking at a flat or down round, which reads as failure even when the company is healthy. Over-raising also dulls the urgency that makes early companies move. Eighteen months of runway removes the forcing function that twelve months creates. And it dilutes you now, at the lowest price your equity will ever be, for capital you deploy slowly and sometimes never.
Under-raising is the opposite trap and it is real. Raise so little that you hit the milestone and have no buffer to run the next process, and you are raising again from a position of weakness, with two months of cash and a deadline every investor can smell. Under-raising also means under-resourcing the proof itself: you get to the milestone late or not at all because you cut the headcount that would have gotten you there. The fix is not a bigger headline number. It is the margin in step three, sized to timeline risk, not to scope.
The planner below is built to keep you out of both.
The artifact: round size vs milestone planner
Work it top to bottom. Each row constrains the next. If you cannot fill a row honestly, that is the finding.
| # | Question | Your answer |
|---|---|---|
| 1 | The one risk this raise removes | We have not yet proven that ___ |
| 2 | The proof (an observable number, not "traction") | ___ |
| 3 | Where you are on that number today | ___ |
| 4 | Months to get from today to the proof | ___ |
| 5 | Monthly burn to run that plan (current + planned hires) | $___ /mo |
| 6 | Core cost to the milestone (row 4 x row 5) | $___ |
| 7 | Timeline margin (20-40% of row 6, for being wrong about when) | $___ |
| 8 | Buffer to run the next raise (3-4 months of burn) | $___ |
| 9 | Round size (rows 6 + 7 + 8) | $___ |
| 10 | Implied post-money at a defensible multiple | $___ |
| 11 | The number you next have to clear to raise up from row 10 | $___ |
Two checks turn the numbers into a decision.
The headline gap. Compare row 9 to the number you wanted before you started. If your gut number is far above row 9, the gap is ego or headline-matching, and you should be able to say which. If your gut number is far below row 9, you are under-resourcing the proof and will arrive late and weak.
The clearance check. Look at row 11. That is the revenue or traction you must reach before the next round prices up instead of flat. Ask plainly: does the capital in row 9 get you past row 11, with margin. If row 9 funds the milestone but the milestone does not clear row 11, you have sized to the wrong proof point, and you are buying a down round eighteen months out.
A worked example
Take a seed-stage B2B SaaS company at $8K MRR. The founder's gut said $3M, because that is what "a seed round" sounds like.
Row 1, the risk: we have not proven a repeatable sales motion beyond founder-led deals. Row 2, the proof: $50K MRR with at least half coming from reps, not the founder. Row 4, the time: about 12 months. Row 5, the burn to run that plan with two AEs and an engineer: $90K/mo. Row 6, core cost: roughly $1.08M. Row 7, timeline margin at 30%: about $324K. Row 8, four months of buffer to run the A: $360K. Row 9, round size: about $1.76M.
Call it $1.8M. At a defensible multiple that is roughly a $9M post, and the number to clear for an up-round Series A is the revenue that supports a meaningfully higher post, somewhere north of $1.5M ARR on a working sales motion. The $1.8M plan gets there. The $3M plan at a $15M post needed the company to roughly triple from a valuation the milestone did not support. Same business. One version raises into a clearable bar. The other raises into a flat round it scheduled for itself.
The point is not that $1.8M is correct and $3M is wrong in general. The point is that the planner produced a number tied to one proof, and the gut produced a number tied to a headline.
Where RoundOS fits
The planner is a manual exercise and it should stay one. You can run it today with this table and an honest hour. What RoundOS does is carry the output forward into the round so the milestone logic does not get lost the moment outreach starts.
The risk in row 1 and the proof in row 2 are the spine of your investor narrative. RoundOS keeps that narrative attached to the round and to the sources it lives in: your metrics, your deck, your notes. When an investor pushes on "why this much," the answer is not improvised. It is the same milestone-to-dollar mapping you built, surfaced against the conversation. As real traction lands, it updates the proof number you are tracking toward, so your follow-ups and updates show movement against the milestone you raised for, not generic activity. The round you described in the planner is the round investors see, conversation after conversation.
Size the round to the proof.
Use RoundOS to connect the amount raised to the milestone, proof, timeline, and investor story it is supposed to fund.